APLP2
APLP2 (amyloid beta precursor like protein 2, also known as APPH and APPL2) is a ubiquitously expressed member of the APP family. It combines protease-inhibitor activity with roles in neuromuscular transmission and synaptic function. Browse Assay Genie's current range of APLP2 research reagents below, or read on for the biology behind the target.
APLP2 may play a role in the regulation of haemostasis. Its soluble form may have inhibitory properties towards coagulation factors, and the protein is reported to inhibit trypsin, chymotrypsin, plasmin, factor XIA and both plasma and glandular kallikrein. It may also interact with cellular G protein signalling pathways, and it may bind the DNA sequence 5'-GTCACATG-3' (the CDEI box). In fibroblasts, APLP2 modulates the Cu/Zn nitric oxide-catalysed autodegradation of GPC1 heparan sulfate side chains.
The APLP2 gene encodes amyloid precursor-like protein 2, a member of the APP family alongside APP and APLP1. The protein is ubiquitously expressed. Its N-terminus carries heparin-, copper- and zinc-binding domains, the middle region contains BPTI/Kunitz inhibitor and E2 domains, and the C-terminus holds the transmembrane and intracellular domains. UniProt records it at the cell membrane and in the nucleus. Multiple alternatively spliced transcript variants encoding different isoforms have been identified, which is relevant when choosing an APLP2 antibody or other reagent for a particular region of the protein.
APLP2 interacts with major histocompatibility complex (MHC) class I molecules. Together with APP, it is required to mediate neuromuscular transmission, spatial learning and synaptic plasticity, and it has been implicated in the pathogenesis of Alzheimer's disease. Earlier names for the gene product include amyloid beta (A4) precursor-like protein 2, and the aliases APPH and APPL2 still appear in the literature.
APLP2 belongs to the APP family and has been implicated in the pathogenesis of Alzheimer's disease.
Together with APP, APLP2 is required for neuromuscular transmission, spatial learning and synaptic plasticity.
APLP2 may regulate haemostasis and inhibits proteases including plasmin, factor XIA and kallikreins.
APLP2 interacts with MHC class I molecules, making it a point of study in membrane protein trafficking and interaction.
APLP2 may help regulate haemostasis, and it inhibits several proteases including trypsin, chymotrypsin, plasmin, factor XIA and kallikreins. It may also interact with G protein signalling pathways. With APP, it is required for neuromuscular transmission, spatial learning and synaptic plasticity.
APLP2 is also known as APPH and APPL2, and was previously named amyloid beta (A4) precursor-like protein 2. Multiple alternatively spliced transcript variants encode different isoforms, so the region targeted by a reagent can matter for which forms it recognises.
Mouse and rat both have an Aplp2 ortholog. APLP2 is a member of the APP family with APP and APLP1, and it has been implicated in the pathogenesis of Alzheimer's disease. Check the datasheet of any product for its validated reactivity.
APLP1, another member of the APP family studied alongside APLP2 in neuronal and synaptic research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q06481; product specifications from Assay Genie datasheets.